High early death rates, treatment resistance, and short survival of Black adolescents and young adults with AML
      QxMD      Google Scholar   
Citation:
Blood Adv vol 6 (19) 5570-5581
Year:
2022
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pmc-release
Note:
Methodological:
No
Biospecimen:
Yes
SDC:
No
Book Volume:
12
Parents:
3649  
Children:
None
Program:
TRP
Primary Committee:
Leuk Corr Sci
Sec. Committees:
   
Pharmas:
 
Grants:
U10CA180821, U10CA180882, U24CA196171;UG1CA283338, UG1CA189824, UG1CA233338, U10CA140158, UG1CA233331, U10CA180867, R35CA197734, UG1CA189850, and 5P30CA016058; the Coleman Leukemia Research Foundation; ASH Junior Faculty Scholar and ASH Bridge Award (AKE); the Leukemia & Lymphoma Society Translational Research Grant (AKE); The Leukemia Research Foundation (AKE); the National Comprehensive Cancer Network Foundation Young Investigator Award (JSB); the Alliance for Clinical Trials in Oncology Scholar Award (JSB);  
Corr. Author:
 
Authors:
                                                             
Networks:
CT063, LAPS-AL002, LAPS-IL057, LAPS-MA036, LAPS-NC010, LAPS-OH007, NC002, NORTHWELL, OH070   
Study
Multiple Studies, or Legacy Studies in Alliance Study:
CALGB-20202, CALGB-8461, CALGB-9665
Phases:
N/A
Keywords:
Regular Article